SamSuka
The Long Investor
The Long Investor

patreon


The LIT Sunday News.

U.S. Stocks Struggle as ‘America First’ Bets Backfire, Europe Surges

Key Developments Impacting U.S. and European Markets

Market Reactions and Asset Shifts

Interest Rates and Growth Expectations

TL;DR

Markets betting on Trump’s ‘America First’ policies have been caught off guard as U.S. stocks underperform due to tariff concerns and slowing growth, while European assets surge on stimulus and defense spending. Fund flows are shifting towards European and emerging markets, as investors re-evaluate U.S. economic risks and the strength of non-U.S. growth.

Markets Face Growth Scare as Tariff Risks Add to Uncertainty

Key Market Developments

Doge’s Government Job Cuts and Economic Impact

TL;DR

The market turmoil is primarily a growth scare, with tariffs exacerbating economic uncertainty. Investor sentiment is at extreme lows, yet stocks remain historically expensive, hinting at potential downside. Meanwhile, Doge’s aggressive government job cuts could weaken the labor market, potentially forcing the Fed into a stagflationary dilemma.

U.S. Companies Brace for Higher Costs as Trump’s Tariffs Take Effect

Key Developments

Market Reaction

TL;DR

Trump’s aggressive trade war is driving up costs across industries, with autos, retail, food, and manufacturing among the hardest hit. Price hikes for cars, electronics, and groceries are likely, while retaliatory tariffs on U.S. agricultural and consumer exports threaten thousands of jobs. As companies scramble to stockpile materials, market uncertainty remains high.

China Criticizes Trump as Tariffs Hit Trade Growth

Key Developments

Market Reaction & Strategic Implications

TL;DR

China’s export growth is slowing, and imports are shrinking as Trump’s 20% tariffs take hold. Beijing hit back at the U.S. with countermeasures, while courting Europe as a trade partner. Economists warn the worst trade impact is yet to come, potentially deepening China’s economic slowdown despite government stimulus efforts.

China Hits U.S. Agriculture as Trade War Escalates

Key Developments

Market & Economic Impact

TL;DR

China retaliated against Trump’s 20% tariffs by slapping duties on $21 billion in U.S. farm goods and restricting U.S. firms' access to key markets. Beijing still hopes for a truce, but tensions are escalating, risking a full-scale Trade War 2.0. U.S. farmers and inflation-sensitive industries are most vulnerable.

Hefei Offers Exclusive Subsidies for Nio’s Battery Swap-Enabled EVs

Key Developments

Market Impact & Implications

TL;DR

Hefei is offering cash subsidies for battery swap-enabled EVs, with Nio and Onvo models receiving up to RMB 10,000 ($1,380) in discounts. This move strengthens Nio’s market position and supports China’s broader push for battery-swapping infrastructure.

Dutch Pension Fund ABP Divests Entire $585M Stake in Tesla Over Musk’s Pay and Labor Concerns

Key Developments

Market Impact & Implications

TL;DR

Dutch pension fund ABP dumped its entire $585M Tesla stake, citing Musk’s excessive pay and labor concerns. This underscores Tesla’s governance risks and comes amid declining European sales despite strong stock performance.

Hims & Hers Faces Major Setback as FDA Halts Compounded GLP-1 Sales

Key Developments in Hims & Hers’ Weight-Loss Business

Hims & Hers ($HIMS) capitalized on the weight-loss drug boom by selling compounded versions of GLP-1 medications like semaglutide and tirzepatide. However, the FDA recently ended the shortage designation, meaning compounding pharmacies must stop bulk production. This move threatens Hims’ rapid expansion into the weight-loss market, which helped drive its stock to an all-time high of $73 in February.

Despite spending heavily on marketing, including a $16M Super Bowl ad, Hims now faces a sharp decline in its GLP-1 revenue stream, forcing a pivot to older weight-loss treatments.

Impact on Hims’ Market Position and Financials

Market and Competitive Risks

TL;DR

Hims & Hers ($HIMS) faces a major challenge as the FDA halts bulk production of compounded GLP-1 weight-loss drugs, a key driver of its recent stock surge. The company now shifts to older, less effective treatments, raising doubts about future growth. With competition from Novo Nordisk and Eli Lilly intensifying, investors question whether Hims’ valuation—built on the weight-loss boom—is sustainable.

Meta Accelerates Voice AI Push with Llama 4 and AI Agents

Key Developments

Market Impact & Implications

TL;DR

Meta is ramping up its voice AI strategy, with Llama 4 focusing on more natural conversations and real-time voice processing. The company is also exploring AI monetization via subscriptions and ads while expanding AI-powered smart glasses and headsets as the next big computing platform.

Broadcom’s Earnings Shine as AI Growth Trajectory Impresses Investors

Key Developments

Market Reaction & Investor Takeaways

TL;DR

Broadcom exceeded earnings expectations, boosted AI customer growth, and avoided margin concerns that weighed on Nvidia. Its AI expansion potential and networking leadership make it a standout in an otherwise volatile semiconductor sector.

Nestlé Adapts Baby Food Strategy Amid Falling Birth Rates

Key Developments

Market & Consumer Trends

TL;DR

Nestlé is adapting to global birth rate declines by shifting to premium baby food while expanding into adult and elderly nutrition. The strategy reflects broader demographic shifts, with higher spending per child and an aging population driving new product focus.

Discord Explores IPO Amid Tech Market Revival

Key Developments

Market Context & Competitive Landscape

TL;DR

Discord is exploring an IPO as market conditions improve, following years of delay. The $15B+ company remains ad-free and focuses on subscription revenue while expanding beyond gaming. A potential tech IPO wave in 2025 could boost its valuation prospects.

Crypto Prices Drop as Trump’s Bitcoin Reserve Falls Short of Expectations

Key Developments

Market Reaction & Outlook

TL;DR

Bitcoin and other cryptocurrencies fell after Trump’s executive order disappointed traders. The US will hold seized BTC as a reserve but won’t actively buy more crypto, deflating hopes of a major government-led rally.

The LIT Sunday News.

Comments

An interesting observation is that a lot of late stage tech are choosing to IPO despite potentially worsening stock market, and almost endless VC liquidity. Seems like a general lean that there’s a bit more to go here on the run

Tony Li

Lovely thanjs

Bercan


More Creators